Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellulon was a pioneering biotechnology company focused on the development and commercialization of microbial cellulose, a high-purity biopolymer produced through bacterial fermentation. Originally established as a division of Monsanto, the company specialized in the production of Acetobacter xylinum-derived cellulose, which possesses unique physical properties such as high water-holding capacity and tensile strength. These characteristics made Cellulon's products highly valuable for medical applications, including advanced wound dressings, surgical implants, and specialized drug delivery systems. The company's technology was eventually integrated into CP Kelco following a series of corporate acquisitions, where it continued to influence the development of bio-based materials for the healthcare and industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellulon.